Market Research Logo

Pre-Clinical CROs Market to 2027 - Global Analysis and Forecasts By Service (Bio-analysis & DMPK Studies, Toxicology, and Other Services); End User (Biopharmaceutical Companies, Government & Academic Institutes, and Medical Device Companies), and Geograph

Pre-Clinical CROs Market to 2027 - Global Analysis and Forecasts By Service (Bio-analysis & DMPK Studies, Toxicology, and Other Services); End User (Biopharmaceutical Companies, Government & Academic Institutes, and Medical Device Companies), and Geography

The global pre-clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.42 Mn in 2018. The pre-clinical CROs market is estimated to grow with a CAGR of 8.1% from 2019-2027.
The market is driven by factors such as, increasing R&D expenditures and higher cost of drug development process in developed countries. However, dearth of skilled professionals may limit the growth of the market to a certain extent.
Increasing R&D expenditures made by the companies has been driving the growth of the pre-clinical CROs market. Research & development (R&D) is a significant and essential part of a company’s business. Pharmaceutical and biotech companies majorly focus on research and development (R&D) to come up with new molecules for various therapeutic applications with the most significant medical and commercial potential. The companies invest majorly on the R&Ds intending to deliver high quality and innovative products to the market. R&D investments made by biopharmaceutical companies has increased over the years. As per a report published by Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion in 2012 to US$ 58.8 billion in 2015. R&D not only leads to huge investment but also leads to the involvement of several years. The process from early detection or design to development to regulatory approval can take more than 10 to 15 years. Throughout the development phase of a drug substance, various testing services are required to check the quality and efficacy of the product. Hence, the pharmaceutical and biotech companies prefer to outsource the services to the contract research organizations (CROs) to save the cost and time, which is expected to drive the growth of the market.
Global pre-clinical CROs were segmented by service and end user. Based on the service segment, the market is categorized as, bio-analysis & DMPK studies, toxicology, and other services. On the basis of end user, the market is classified as, biopharmaceutical companies, government & academic institutes, and medical device companies.
Some of the major primary and secondary sources included in the report include, World Health Organization, Association of Clinical Research Organization, European Federation of Pharmaceutical Industries and Associations, European CRO Federation, and Pharmaceutical Research and Manufacturers of America, among others.


1. Introduction1.1 Scope of the Study1.2 The Insight Partners Research Report Guidance1.3 Market Segmentation
1.3.1 Global Pre-Clinical CROs Market – By Service1.3.2 Global Pre-Clinical CROs Market – By End User1.3.3 Global Pre-Clinical CROs Market – By Geography
2. Global Pre-Clinical CROs Market – Key Takeaways
3. Research Methodology3.1 Coverage3.2 Secondary Research3.3 Primary Research
4. Global Pre-Clinical CROs Market – Market Landscape4.1 Overview4.2 PEST Analysis
4.2.1 North America PEST Analysis4.2.2 Europe PEST Analysis4.2.3 Asia Pacific PEST Analysis4.2.4 Middle East & Africa PEST Analysis4.2.5 South & Central America PEST Analysis
4.3 Expert Opinions
5. Global Pre-Clinical CROs Market – Key Industry Dynamics5.1 Key Market Drivers
5.1.1 Increasing R&D Expenditures5.1.2 Higher Cost of Drug Development Process in Developed Countries
5.2 Key Market Restraint
5.2.1 Dearth of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Rising Biosimilars and Biologics Market
5.4 Future Trends
5.4.1 Increasing Number of Clinical Trials
5.5 Impact Analysis
6. Pre-Clinical CROs Market – Global Analysis6.1 Global Pre-Clinical CROs Market Revenue Forecasts And Analysis6.2 Global Pre-Clinical CROs Market, By Geography - Forecasts And Analysis6.3 Performance of Key Players
7. Global Pre-Clinical CROs Market Analysis– by Service7.1 Overview7.2 Global Pre-Clinical CROs Market, By Service 2018 & 2027 (%)7.3 Bio-Analysis and DMPK Studies Market
7.3.1 Overview7.3.2 Global Bio-Analysis and DMPK Studies Market Revenue and Forecasts to 2027 (US$ Mn)7.3.3 Toxicology Market7.3.3.1 Overview7.3.3.2 Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)7.3.4 Other Services Market7.3.4.1 Overview7.3.4.2 Global Other Services Market Revenue and Forecasts to 2027 (US$ Mn)
8. Global Pre-Clinical CROs Market Analysis – by End User8.1 Overview8.2 Global Pre-Clinical CROs Market, By End User 2018 & 2027 (%)8.3 Biopharmaceutical Companies Market
8.3.1 Overview8.3.2 Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Government & Academic Institutes Market
8.4.1 Overview8.4.2 Global Government & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Medical Device Companies Market
8.5.1 Overview8.5.2 Global Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9. Pre-Clinical CROs Market Revenue and Forecasts to 2027 – Geographical Analysis9.1 North America Pre-Clinical CROs Market
9.1.1 Overview9.1.2 North America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.1.3 North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.1.4 North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.1.5 North America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)9.1.6 US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.1.6.1 US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.1.6.2 US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.1.6.3 US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.1.7 Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.1.7.1 Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.1.7.2 Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.1.7.3 Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.1.8 Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.1.8.1 Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.1.8.2 Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.1.8.3 Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2 Europe Pre-Clinical CROs Market
9.2.1 Overview9.2.2 Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.3 Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.2.4 Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.2.5 Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)9.2.6 UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.6.1 UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.6.2 UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.2.6.3 UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.2.7 Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.7.1 Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.7.2 Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.2.7.3 Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.2.8 France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.8.1 France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.8.2 France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.2.8.3 France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.2.9 Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.9.1 Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.9.2 Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.2.9.3 Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.2.10 Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.10.1 Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.2.10.2 Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.2.10.3 Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3 Asia Pacific Pre-Clinical CROs Market
9.3.1 Overview9.3.2 Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.3 Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.3.4 Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.3.5 Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)9.3.6 China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.6.1 China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.6.2 China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.3.6.3 China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.3.7 India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.7.1 India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.7.2 India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.3.7.3 India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.3.8 Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.8.1 Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.8.2 Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.3.8.3 Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.3.9 Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.9.1 Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.9.2 Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.3.9.3 Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.3.10 South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.10.1 South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.3.10.2 South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.3.10.3 South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Middle East & Africa Pre-Clinical CROs Market
9.4.1 Overview9.4.2 Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.4.3 Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.4.4 Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.4.5 Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)9.4.6 South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.4.6.1 South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.4.6.2 South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.4.6.3 South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.4.7 Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.4.7.1 Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.4.7.2 Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.4.7.3 Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.4.8 UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.4.8.1 UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.4.8.2 UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.4.8.3 UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5 South And Central America Pre-Clinical CROs Market
9.5.1 Overview9.5.2 South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.5.3 South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.5.4 South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.5.5 South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)9.5.6 Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.5.6.1 Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.5.6.2 Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.5.6.3 Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)9.5.7 Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.5.7.1 Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)9.5.7.2 Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)9.5.7.3 Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. Pre-Clinical CROs Market – Industry Landscape10.1 Overview10.2 Growth Strategies in the Pre-Clinical CROs Market, 2016-201910.3 Organic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)
10.4.1 Expansion & Other Activities10.4.1.1 Recent Expansion & Other Activities By Players In The Pre-Clinical CROs Market10.4.2 Product Launches10.4.2.1 Recent Product Launches By Players In The Pre-Clinical CROs Market
10.5 Inorganic Growth Strategies
10.5.1 Overview
10.6 Inorganic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)
10.6.1 Acquisitions10.6.1.1 Recent Acquisitions By Players In The Pre-Clinical CROs Market10.6.2 Agreements & Collaborations10.6.2.1 Recent Agreements & Collaborations By Players In The Pre-Clinical CROs Market10.6.3 Partnerships10.6.3.1 Recent Partnerships By Players In The Pre-clinical CROs Market
11. Pre-Clinical CROs Market–Key Company Profiles11.1 MD Biosciences, Inc.
11.1.1 Key Facts11.1.2 Business Description11.1.3 Financial Overview11.1.4 Services Portfolio11.1.5 SWOT Analysis11.1.6 Key Developments
11.2 WuXi AppTec
11.2.1 Key Facts11.2.2 Business Description11.2.3 Financial Overview11.2.4 Service Portfolio11.2.5 SWOT Analysis11.2.6 Key Developments
11.3 Pharmaceutical Product Development, LLC.
11.3.1 Key Facts11.3.2 Business Description11.3.3 Financial Overview11.3.4 Service Portfolio11.3.5 SWOT Analysis11.3.6 Key Developments
11.4 Covance Inc.
11.4.1 Key Facts11.4.2 Business Description11.4.3 Financial Information11.4.4 Service Portfolio11.4.5 SWOT Analysis11.4.6 Key Developments
11.5 Charles River
11.5.1 Key Facts11.5.2 Business Description11.5.3 Financial Overview11.5.4 Services Portfolio11.5.5 SWOT Analysis11.5.6 Key Developments
11.6 PRA Health Sciences, Inc.
11.6.1 Key Facts11.6.2 Business Description11.6.3 Financial Overview11.6.4 Service Portfolio11.6.5 SWOT Analysis11.6.6 Key Developments
11.7 Medpace
11.7.1 Key Facts11.7.2 Business Description11.7.3 Financial Overview11.7.4 Service Portfolio11.7.5 SWOT Analysis11.7.6 Key Developments
11.8 Parexel International Corporation
11.8.1 Key Facts11.8.2 Business Description11.8.3 Financial Information11.8.4 Service Portfolio11.8.5 SWOT Analysis11.8.6 Key Developments
11.9 ICON Plc
11.9.1 Key Facts11.9.2 Business Description11.9.3 Financial Overview11.9.4 Service Portfolio11.9.5 SWOT Analysis11.9.6 Key Developments
11.10 Eurofins Scientific
11.10.1 Key Facts11.10.2 Business Description11.10.3 Financial Overview11.10.4 Product Portfolio11.10.5 SWOT Analysis11.10.6 Key Developments
12. Appendix12.1 About The Insight Partners12.2 Glossary of Terms
LIST OF TABLES
Table 1. R&D Investments by Major Pharmaceutical Companies
Table 2. R&D Investments by PhRMA Member Companies,2016
Table 3. Number of Studies Registered for Clinical Trials
Table 4. North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 5. North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 6. US: R&D Investments by Pharmaceutical Companies, (2015-2016)
Table 7. US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 8. US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 9. Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 10. Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 11. Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 12. Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 13. Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 14. Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 15. UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 16. UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 17. Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 18. Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 19. France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 20. France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 21. Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 22. Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 23. Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 24. Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 25. Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 26. Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 27. China: Major global pharmaceutical companies by R&D investments, 2013
Table 28. China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 29. China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 30. India: R&D spending of Pharmaceutical companies (2010 & 2017)
Table 31. India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 32. India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 33. Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 34. Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 35. Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 36. Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 37. South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 38. South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 39. Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 40. Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 41. South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 42. South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 43. Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 44. Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 45. UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 46. UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 47. South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 48. South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 49. Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 50. Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 51. Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
Table 52. Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 53. Recent Expansion & Other Activities By Players In The Pre-Clinical CROs Market
Table 54. Recent Product Launches in the Pre-Clinical CROs Market
Table 55. Recent Acquisitions By Players In The Pre-Clinical CROs Market
Table 56. Recent Agreements & Collaborations By Players In The Pre-Clinical CROs Market
Table 57. Recent Partnerships By Players In The Pre-clinical CROs Market
Table 58. Glossary of Terms, Pre-Clinical CROs Market
LIST OF FIGURES
Figure 1. Pre-Clinical CROs Market Segmentation
Figure 2. Pre-Clinical CROs Market Segmentation, by Region
Figure 3. Global Pre-Clinical CROs Market Overview
Figure 4. Imaging Segment Held Largest Share Of The Service Segment In Pre-Clinical CROs Market
Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Pre-Clinical CROs Market, By Geography (US$ Mn)
Figure 7. Global Pre-Clinical CROs Market- Leading Country Markets (US$ Mn)
Figure 8. Global Pre-Clinical CROs Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia - Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Number of Approvals for NDA & BLA (2005 to 2016)
Figure 15. Impact Analysis of Driver and Restraints Pertaining to Pre-Clinical CROs Market
Figure 16. Global Pre-Clinical CROs Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 17. Global Pre-Clinical CROs Market – by Geography Forecasts and Analysis – 2018- 2027
Figure 18. Prominent Players in the Pre-Clinical CROs Market
Figure 19. Global Pre-Clinical CROs Market, by Service 2018 & 2027 (%)
Figure 20. Global Bio-Analysis and DMPK Studies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Global Other Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Global Pre-Clinical CROs Market, by End User 2018 & 2027 (%)
Figure 24. Global Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Global Government & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Global Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. North America Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)
Figure 28. North America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. North America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
Figure 30. US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Europe Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)
Figure 34. Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
Figure 36. UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Asia Pacific Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)
Figure 42. Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
Figure 44. China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 46. Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 48. South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. Middle East & Africa Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)
Figure 50. Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
Figure 52. South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 54. UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. South and Central America Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)
Figure 56. South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
Figure 58. Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 60. Growth Strategies in the Pre-Clinical CROs Market, 2016-2019
Figure 61. Organic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)
Figure 62. Inorganic Developments in the Pre-Clinical CROs Market, 2016-2019(%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook